S. 2737 · 118th Congress

FDA Review of Efficacy of EERW Double-Blinds of Opioids Act

Stage
In committee
Sponsor
Joe Manchin
Introduced
2023-09-07
Latest action
2023-09-07 · Introduced in Senate

Action history

  1. 2023-09-07Introduced in Senate
  2. 2023-09-07Read twice and referred to the Committee on Health, Education, Labor, and Pensions.